Clinical Trial Update: Multicentre Trial of Suboxone in Opiate-dependent Subjects in Taiwan [Phase 4]

View source ↗

Summary

A multicentre Phase 4 trial of Suboxone (buprenorphine/naloxone) for opioid dependence in Taiwan has completed. The study was sponsored by Indivior Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Dependence

Drugs mentioned

• SUBOXONE (buprenorphine hydrochloride, naloxone hydrochloride)

Snippet

Sponsor: Indivior Inc. | Conditions: Opiate Dependence | Phase 4 | Status: COMPLETED